CN Patent

CN102078305B — 苯达莫司汀冻干药物组合物

Assigned to Safran SA · Expires 2014-05-28 · 12y expired

What this patent protects

本发明提供了苯达莫司汀冻干药物组合物。本发明进一步提供了生产冻干苯达莫司汀的方法。该药物制剂可以用于任何对苯达莫司汀的治疗敏感的疾病，例如肿瘤性疾病。

USPTO Abstract

本发明提供了苯达莫司汀冻干药物组合物。本发明进一步提供了生产冻干苯达莫司汀的方法。该药物制剂可以用于任何对苯达莫司汀的治疗敏感的疾病，例如肿瘤性疾病。

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN102078305B
Jurisdiction: CN
Classification: —
Expires: 2014-05-28
Drug substance claim: No
Drug product claim: No
Assignee: Safran SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.